相关实验视频

Updated: May 28, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

在急性髓性白血病中,Src抑制增强了MCL-1抗剂的活性

Xiaoyan Hu¹, Lin Li¹, Jewel Nkwocha¹

¹Division of Hematology/Oncology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.

Signal transduction and targeted therapy

|February 9, 2025

概括

像博苏替尼 (SKI-606) 这样的SRC抑制剂通过阻断补偿性MCL-1积累,导致协同的癌细胞死亡来增强MCL-1抗剂对急性髓性白血病 (AML) 的有效性.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

髓性白血病病因子1 (MCL-1) 在白血病发生过程中至关重要,驱动着像S63845.5这样的MCL-1对手的发展.
在急性髓性白血病 (AML) 中,MCL-1 抗剂的疗效通常受到通过无素-蛋白酶体系统的补偿性 MCL-1 积累的限制.

研究的目的:

研究具有Src抑制活性的激酶抑制剂,如博苏替尼 (SKI-606),如何克服AML中MCL-1抗剂的耐药性.
阐明结合MCL-1抗剂和Src抑制剂的协同抗白血病作用的分子机制.

主要方法:

在多种AML细胞系中同时使用MCL-1抗剂和SKI-606.
短毛RNA (shRNA) 介导的Src或MCL-1的淘汰.
宫外表达的MCL-1. 的表达.
对STAT3酸化,c-Myc和BCL-xL表达,BAX/BAK激活和NOXA诱导的分析.
使用AML细胞系异种移植和患者衍生异种移植 (PDX) 模型的体内研究.

主要成果:

结合MCL-1抗剂和SKI-606治疗在AML细胞系中协同诱导了亡.
Src 抑制阻断了 MCL-1 抗剂诱导的 MCL-1 上调,促进了降解性无化和下调.
组合疗法减少了酸化的STAT3,c-Myc和BCL-xL,同时增强了BAX/BAK激活和NOXA诱导.
该疗法有效地杀死主要的AML细胞,包括原始细胞,对正常的造血细胞和心肌细胞的毒性最小.
在体内观察到生存率和瘤负担减少的显著改善.

结论:

像SKI-606这样的Src抑制剂通过防止补偿性MCL-1积累,强化AML中的MCL-1抗活性.
这一策略破坏了STAT3信号传递,并通过NOXA诱导促进了细胞亡.
组合疗法在治疗AML和潜在的其他恶性瘤方面表现有希望.

更多相关视频

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...